Fernández-Alfonso MS - Search Results

1

Chronic losartan treatment decreases angiotensin II-mediated facilitation of noradrenaline release in the caudal artery of spontaneously hypertensive rats.

Ruiz-Gayo M, Somoza B, Bravo R, Fernández-Alfonso MS, González C. Ruiz-Gayo M, et al. Life Sci. 2000 Nov 17;67(26):3153-62. doi: 10.1016/s0024-3205(00)00900-0. Life Sci. 2000. PMID: 11191622

2

Chemical Characterization, Antioxidant Capacity and Anti-Oxidative Stress Potential of South American Fabaceae Desmodium tortuosum.

Rodríguez JL, Berrios P, Clavo ZM, Marin-Bravo M, Inostroza-Ruiz L, Ramos-Gonzalez M, Quispe-Solano M, Fernández-Alfonso MS, Palomino O, Goya L. Rodríguez JL, et al. Among authors: fernandez alfonso ms. Nutrients. 2023 Feb 1;15(3):746. doi: 10.3390/nu15030746. Nutrients. 2023. PMID: 36771451 Free PMC article.

3

Early induction of angiotensin I-converting enzyme in rat carotid artery after balloon injury.

Fernandez-Alfonso MS, Martorana PA, Licka I, van Even P, Trobisch D, Schölkens BA, Paul M. Fernandez-Alfonso MS, et al. Hypertension. 1997 Aug;30(2 Pt 1):272-7. doi: 10.1161/01.hyp.30.2.272. Hypertension. 1997. PMID: 9260992

4

Modulation of angiotensin-converting enzyme by nitric oxide.

Ackermann A, Fernández-Alfonso MS, Sánchez de Rojas R, Ortega T, Paul M, González C. Ackermann A, et al. Br J Pharmacol. 1998 May;124(2):291-8. doi: 10.1038/sj.bjp.0701836. Br J Pharmacol. 1998. PMID: 9641545 Free PMC article.

5

Nitric oxide and the renin-angiotensin system. Is there a physiological interplay between the systems?

Fernández-Alfonso MS, González C. Fernández-Alfonso MS, et al. J Hypertens. 1999 Oct;17(10):1355-61. doi: 10.1097/00004872-199917100-00001. J Hypertens. 1999. PMID: 10526894 Review.

6

Differential effect of chronic antihypertensive treatment on vascular smooth muscle cell phenotype in spontaneously hypertensive rats.

Bravo R, Somoza B, Ruiz-Gayo M, González C, Ruilope LM, Fernández-Alfonso MS. Bravo R, et al. Hypertension. 2001 May;37(5):E4-E10. doi: 10.1161/01.hyp.37.5.e4. Hypertension. 2001. PMID: 11358952

7

The upregulation of angiotensin-converting enzyme during neointima formation does not have functional consequences.

González C, Gómez C, Molero F, Fernández-Alfonso MS. González C, et al. Life Sci. 2001 Sep 7;69(16):1851-60. doi: 10.1016/s0024-3205(01)01265-6. Life Sci. 2001. PMID: 11693265

8

Cholecystokinin induces cerebral vasodilatation via presynaptic CCK2 receptors: new implications for the pathophysiology of panic.

Sánchez-Fernández C, González C, Mercer LD, Beart PM, Ruiz-Gayo M, Fernández-Alfonso MS. Sánchez-Fernández C, et al. J Cereb Blood Flow Metab. 2003 Mar;23(3):364-70. doi: 10.1097/01.WCB.0000043948.67811.8F. J Cereb Blood Flow Metab. 2003. PMID: 12621311

9

Chronic l-arginine treatment reduces vascular smooth muscle cell hypertrophy through cell cycle modifications in spontaneously hypertensive rats.

Somoza B, González C, Cachofeiro V, Lahera V, Fernández-Alfonso MS. Somoza B, et al. J Hypertens. 2004 Apr;22(4):751-8. doi: 10.1097/00004872-200404000-00018. J Hypertens. 2004. PMID: 15126917

10

A novel role for cholecystokinin: regulation of mesenteric vascular resistance.

Sánchez-Fernández C, González MC, Beart PM, Mercer LD, Ruiz-Gayo M, Fernández-Alfonso MS. Sánchez-Fernández C, et al. Regul Pept. 2004 Sep 15;121(1-3):145-53. doi: 10.1016/j.regpep.2004.04.018. Regul Pept. 2004. PMID: 15256285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters